CN1377274A - 用母牛分枝杆菌治疗慢性病毒感染 - Google Patents

用母牛分枝杆菌治疗慢性病毒感染 Download PDF

Info

Publication number
CN1377274A
CN1377274A CN00803475A CN00803475A CN1377274A CN 1377274 A CN1377274 A CN 1377274A CN 00803475 A CN00803475 A CN 00803475A CN 00803475 A CN00803475 A CN 00803475A CN 1377274 A CN1377274 A CN 1377274A
Authority
CN
China
Prior art keywords
infection
chronic viral
treatment
viral infection
cow mycobacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN00803475A
Other languages
English (en)
Chinese (zh)
Inventor
J·L·斯坦福
G·A·W·罗克
C·A·斯坦福
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Silence Therapeutics PLC
Original Assignee
Stanford Rook Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanford Rook Ltd filed Critical Stanford Rook Ltd
Publication of CN1377274A publication Critical patent/CN1377274A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN00803475A 1999-02-16 2000-02-16 用母牛分枝杆菌治疗慢性病毒感染 Pending CN1377274A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9903539.6 1999-02-16
GBGB9903539.6A GB9903539D0 (en) 1999-02-16 1999-02-16 Therapy using M.Vaccae

Publications (1)

Publication Number Publication Date
CN1377274A true CN1377274A (zh) 2002-10-30

Family

ID=10847890

Family Applications (1)

Application Number Title Priority Date Filing Date
CN00803475A Pending CN1377274A (zh) 1999-02-16 2000-02-16 用母牛分枝杆菌治疗慢性病毒感染

Country Status (26)

Country Link
US (1) US6596282B1 (fr)
EP (1) EP1152768B1 (fr)
JP (1) JP2002537266A (fr)
KR (1) KR20010113691A (fr)
CN (1) CN1377274A (fr)
AP (1) AP2001002254A0 (fr)
AT (1) ATE246930T1 (fr)
AU (1) AU766113B2 (fr)
BR (1) BR0008269A (fr)
CA (1) CA2361925A1 (fr)
DE (1) DE60004481T2 (fr)
DK (1) DK1152768T3 (fr)
ES (1) ES2204508T3 (fr)
GB (1) GB9903539D0 (fr)
HK (1) HK1038697B (fr)
HU (1) HUP0105474A3 (fr)
ID (1) ID30441A (fr)
MX (1) MXPA01008243A (fr)
NO (1) NO20013939L (fr)
NZ (1) NZ513320A (fr)
PL (1) PL350577A1 (fr)
PT (1) PT1152768E (fr)
RU (1) RU2001125429A (fr)
TR (1) TR200102388T2 (fr)
WO (1) WO2000048615A2 (fr)
ZA (1) ZA200106248B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0010496D0 (en) * 2000-04-28 2000-06-14 Stanford Rook Ltd Treatment of conditions of the central nervous system
US20070098746A1 (en) * 2005-11-02 2007-05-03 Nichols William M Multi-layered coating technology for taste masking
CN111281893B (zh) * 2020-03-02 2021-11-19 广西医科大学第一附属医院 注射用母牛分枝杆菌在制备用于防治covid-19的药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8917256D0 (en) 1989-07-28 1989-09-13 Univ London Biological preparation and its use
GB9219425D0 (en) * 1992-09-14 1992-10-28 Univ London Therapeutic agent and its use
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
ES2104731T3 (es) * 1990-11-08 1997-10-16 Univ London Micobacterium utilizado como adyuvante para antigenos.
BR9814432A (pt) 1997-12-23 2000-10-10 Genesis Res & Dev Corp Ltd Composições derivadas de mycobacterium vaccae e processo para seu uso

Also Published As

Publication number Publication date
DE60004481D1 (de) 2003-09-18
DK1152768T3 (da) 2003-11-24
CA2361925A1 (fr) 2000-08-24
PL350577A1 (en) 2002-12-30
KR20010113691A (ko) 2001-12-28
GB9903539D0 (en) 1999-04-07
JP2002537266A (ja) 2002-11-05
NO20013939L (no) 2001-10-04
ES2204508T3 (es) 2004-05-01
ZA200106248B (en) 2002-01-23
TR200102388T2 (tr) 2002-10-21
EP1152768B1 (fr) 2003-08-13
AU2561100A (en) 2000-09-04
ID30441A (id) 2001-12-06
AU766113B2 (en) 2003-10-09
US6596282B1 (en) 2003-07-22
WO2000048615A3 (fr) 2000-12-14
PT1152768E (pt) 2003-12-31
NO20013939D0 (no) 2001-08-14
MXPA01008243A (es) 2002-08-30
RU2001125429A (ru) 2003-06-10
BR0008269A (pt) 2001-11-06
AP2001002254A0 (en) 2001-09-30
ATE246930T1 (de) 2003-08-15
HUP0105474A3 (en) 2003-11-28
HUP0105474A2 (hu) 2002-05-29
WO2000048615A2 (fr) 2000-08-24
NZ513320A (en) 2004-04-30
HK1038697A1 (en) 2002-03-28
EP1152768A2 (fr) 2001-11-14
DE60004481T2 (de) 2004-06-24
HK1038697B (zh) 2004-03-19

Similar Documents

Publication Publication Date Title
US4053582A (en) Attenuated fowl pox virus preparation for the treatment of infectious diseases, method for the manufacture thereof, and its use
JP7572062B2 (ja) 単離されたロドコッカス・ルーバーの細胞壁骨格のヒトパピローマウイルス感染症を治療する医薬の製造における使用
KR100272743B1 (ko) Hiv 감염의 치료에 유용한 미코박테리움 바케로부터의 항원물질
Higgins et al. Recurrent Kaposi's varicelliform eruption in Darier's disease
Southam et al. Pathogenicity and oncolytic capacity of RI virus strain RI-67 in man
EP0484438B1 (fr) Preparation biologique et son utilisation
CN101151049A (zh) 旋盘尾丝虫的天然产物的佐剂和免疫加强性能
US4315914A (en) Pharmaceutical compositions useful as cellular immunopotentiator and antitumor agent and process for production thereof
CN105535964A (zh) 一种具有免疫调节作用的双链聚核苷酸—ε-聚赖氨酸—硫酸聚糖复合物及其制备使用方法
Gurevitz et al. Cryptococcus neoformans vertebral osteomyelitis
CN1377274A (zh) 用母牛分枝杆菌治疗慢性病毒感染
EP0037441B1 (fr) Compositions pharmaceutiques utilisables comme immunostimulant cellulaire et comme agent anti-tumeur, procédé de préparation et microorganisme utilisé
CN1485343A (zh) 抗性病特异性IgY的制备方法及其组合制剂
CN1384119A (zh) 抗禽类病毒性疫病的复合卵黄抗体及其制备和应用
CN1548152A (zh) 溶菌酶对严重急性呼吸道综合症的治疗和预防作用
Junge et al. Clinical presentation and antiviral therapy for poxvirus infection in pudu (Pudu puda)
Rose et al. Treatment of rickettsialpox with aureomycin
Mathers The varieties of pneumococci causing lobar pneumonia, with especial reference to their biologic differences
US6432714B2 (en) Prophylactic and therapeutic method
GOBLE et al. Effects of Certain Surface‐Active Po lyoxyethylene Ethers in Experimental Protozoal Infections
CN117003860A (zh) 猫杯状病毒卵黄抗体的制备及其应用
US6210684B1 (en) Method for delaying the onset of AIDS
JPH06508634A (ja) 弱毒化復帰変異体血清型１マレク病ワクチン
CN1756565A (zh) 用于治疗分枝杆菌感染的组合物
CN1917900A (zh) 猪红斑丹毒丝菌－副猪嗜血菌疫苗及其使用方法

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned
C20 Patent right or utility model deemed to be abandoned or is abandoned